Summary
Pituitary responsiveness to thyrotrophin releasing hormone (TRH) and luteinizing hormone releasing hormone (LHRH) was studied in thirty one male diabetics, of whom sixteen were insulin-dependent and fifteen on oral antidiabetic agents. Ten age-matched controls were also studied. TRH and LHRH were simultaneously administered intravenously, each in a small dose of 10 μg followed two hours later by 190 μg and 90 μg respectively. Basal hormone levels were measured in a further group of thirty six patients (twelve on insulin, twelve on oral agents and twelve on dietary restrictions alone).
Higher thyrotrophin (TSH) response was observed following the small dose of TRH in the patients treated with oral agents than in the control subjects. The response of prolactin was lower in patients treated with oral agents compared with those treated with insulin. There was no difference in plasma T3 and T4 levels in the patients treated with insulin or oral agents. Significantly higher basal growth hormone (GH) levels were observed in the diabetics. The insulin-dependent group showed a more marked response of GH to TRH/LHRH. No response was observed in the controls. Plasma testosterone levels were significantly lower in the oral agent group (13.8 nmol/l) than in the insulin group (19.4 nmol/l), patients on dietary restrictions (18.4 nmol/l) and the control subjects (19.0 nmol/l). The LH response to the smaller dose of LHRH was impaired in patients on insulin and oral agents. There was a significant difference in FSH response between impotent and sexually normal patients.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Rundles, R.W.: Diabetic neuropathy. Medicine (Baltimore)24, 111–160 (1945)
Rubin, A., Babbott, D.: Impotence and diabetes mellitus. J.A.M.A.168, 498–500 (1958)
Faerman, I., Vilar, O., Rivarola, M.A., Rosner, J.J., Jadzinsky, M.N., Fox, D., Lloret, A.P., Bernstein-Hahn, L., Saraceni, D.: Impotence and diabetes: Studies of androgenic function in diabetic impotent men. Diabetes21, 23–30 (1972)
Kolodny, R.C., Kahn, C.B., Goldstein, H.H., Barnett, D.M.: Sexual dysfunction in diabetic men. Diabetes23, 306–309 (1974)
Ellenberg, M.: Impotence in diabetes: The neurologic factor. Ann. Intern. Med.72, 213–219 (1971)
Cooper, A.J.: Diagnosis and management of “endocrine impotence”. Br. Med. J.1972 II, 34–36
Kent, J.R.: Gonadal function in impotent diabetic males. Diabetes15, 537 (1966)
Schoffling, K., Federlin, K., Ditschuneit, H., Pfeisser, E.S.: Disorders of sexual function in male diabetics. Diabetes12, 519–527 (1963)
Rastogi, G.K., Chakraborti, J., Sinha, M.K.: Serum gonadotrophin (LH and FSH) and their response to synthetic LHRH in diabetic men with and without impotence. Horm. Metab. Res.6, 335–336 (1974)
Distiller, L.A., Sagel, J., Morley, J.E., Joffe, B.I., Seftel, H.C.: Pituitary responsiveness to luteinizing hormone-releasing hormone in insulin-dependent diabetes mellitus. Diabetes24, 378–380 (1975)
Wright, A.D., London, D.R., Holder, G., Williams, J.W., Rudd, B.J.: Luteinizing release hormone tests in impotent diabetic males. Diabetes25, 975–977 (1976)
Hunton, R.B., Wells, M.V., Skipper, E.W.: Hypothyroidism in diabetics treated with sulphonylurea. Lancet1965 II, 449–451
Kaufmann, B. M., Tunbridge, W. M. G., Harsoulis, P., Kuku, S. F., Lowy, C., Fraser, T. R.: The prevalence of raised TSH levels among clinically euthyroid diabetics. Abstracts of the autumn meeting of the British Diabetic Association, Medical and Scientific Section 1975
Hansen, A.P.: Serum growth hormone patterns in female juvenile diabetics. J. Clin. Endocrinol. Metab.36, 638–646 (1973)
Johansen, K., Hansen, A.P.: Diurnal serum growth hormone levels in poorly- and well-controlled diabetics. Diabetes20, 239–45 (1971)
Wood, P.J., Smith, J., Marks, V.: Notes on the radioimmunoassay of human thyrotrophin. Ann. Clin. Biochem.12, 196–199 (1975)
Sinha, Y.N., Selby, F.W., Lewis, U.J., Vanderlaan, W.P.: Homologous radioimmunoassay for prolactin. J. Clin. Endocrinol. Metab.36, 509–516 (1973)
Wood, P.J., Shahwan, M.M., Marks, V.: Radioimmunoassay of plasma prolactin. Lancet1975 II, 1040
Wilde, C.E., Orr, A.H., Bagshawe, K.D.: A radioimmunoassay for human chorionic gonadotrophin. Nature205, 191–193 (1965)
Rosenfield, R.L.: Plasma testosterone binding globulin and indexes of the concentration of unbound plasma androgens in normal and hirsute subjects. J. Clin. Endocrinol. Metab.32, 717–728 (1971)
Rappaport, B., Refetoff, S., Fang, V.S., Friesen, H.G.: Suppression of serum thyrotropin (TSH) by L. dopa in chronic hypothyroidism: Interrelationships in the regulation of TSH and prolactin secretion. J. Clin. Endocrinol. Metab.36, 256–262 (1973)
L'Hermite, M., Robyn, C., Golstein, J., Rothenbuchner G., Birk, J., Loos, U., Bonnyns, M., Vanhaelst, L.: Prolactin and thyrotropin in thyroid disease: lack of evidence for a physiological role of thyrotropin-releasing hormone in the regulation of prolactin secretion. Horm. Metab. Res.6, 190–195 (1974)
Kannan, C., Akbar, M., Begum, F., Dwarakanathan, A., Burke, G.: Dissociation between TSH and prolactin dynamics in treated thyrotoxicosis. Clin. Endocrinol. (Oxf.)5, 331–340 (1976)
Czernichow, P., Dauzet, M.C., Broyer, M., Rappaport, R.: Abnormal TSH, PRL and GH response to TSH releasing factor in chronic renal failure. J. Clin. Endocrinol. Metab.43, 630–637 (1976)
Irie, M., Tsushima, T.: Increase of serum growth hormone concentration following thyrotropin-releasing hormone injection in patients with acromegaly or gigantism. J. Clin. Endocrinol. Metab.35, 97–100 (1972)
Maeda, K., Kato, Y., Yamaguchi, N., Chihara, K., Ohgo, S., Iwasaki, Y., Yashimoto, Y., Moridera, K., Kuromaru, S., Imura, H.: Growth hormone release following thyrotropin releasing hormone injection with patients with anorexia nervosa. Acta Endocrinol. (Kbh.)81, 1–8 (1976)
Maeda, K., Kato, Y., Ohgo, S., Chihara, K., Yoshimoto, Y., Yamaguchi, N., Kuromaru, S., Imura, H.: Growth hormone and prolactin release after injection of thyrotropin-releasing hormone in patients with depression. J. Clin. Endocrinol. Metab.40, 501–505 (1975)
Faglia, G., Beck-Peccoz, P., Travaglini, P., Paracchi, A., Spada, A., Lewin, A.: Elevation in plasma growth hormone concentration after luteinizing hormone-releasing hormone (LRH) in patients with active acromegaly. J. Clin. Endocrinol. Metab.37, 338–340 (1973)
Burns, J.J., Conney, A.H.: Enzyme stimulation and inhibition in the metabolism of drugs. Proc. R. Soc. Med. (Suppl.)58, 955–960 (1965)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shahwan, M.M., Spathis, G.S., Fry, D.E. et al. Differences in pituitary and testicular function between diabetic patients on insulin and oral anti-diabetic agents. Diabetologia 15, 13–17 (1978). https://doi.org/10.1007/BF01219321
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF01219321